The Relationship Between Parathyroid Hormone and 25-Hydroxyvitamin D During and After Pregnancy.
There is debate about whether women may need greater vitamin D supplementation when pregnant. However, it is unclear whether the 25-hydroxyvitamin D (25-OH-D) concentration required for suppression of PTH (ie, suggesting vitamin D sufficiency) differs between pregnancy and the nongravid state. To systematically characterize the relationship between 25-OH-D and PTH during and after pregnancy. In this study, 468 women underwent serial assessment of serum 25-OH-D and PTH in late pregnancy, at 3 months postpartum, and at 12 months postpartum. At each visit, segmented regression analysis was performed to: 1) determine the best model to fit the relationship between 25-OH-D and PTH; and 2) identify the 25-OH-D threshold above which PTH is maximally suppressed. Serum 25-OH-D and PTH were inversely correlated at each of the pregnancy (r = −0.33; P < .0001), 3 months postpartum (r = −0.37; P < .0001), and 12 months postpartum (r = −0.34; P < .0001) assessments. In pregnancy, PTH first rises when 25-OH-D falls below 82 nmol/L (95% confidence interval, 61–103) and follows a linear relationship with declining 25-OH-D thereafter. In contrast, at both postpartum visits, there was a curvilinear relationship between 25-OH-D and PTH below the 25-OH-D threshold at which PTH is suppressed (71 nmol/L [61–81] at 3 months and 81 nmol/L [61–100] at 12 months). The 25-OH-D thresholds for PTH suppression in pregnancy and at 3 and 12 months postpartum were not significantly different from one another (all pairwise P ≥ .26). Although the shape of the relationship between 25-OH-D and PTH differs between pregnancy and the postpartum, the 25-OH-D thresholds for PTH suppression are similar, supporting comparable targets for vitamin D supplementation.